Report Detail
Global Home Insulin Delivery (Dosing) Devices Market Growth 2022-2028
- RnM4417084 |
- 02 April, 2022 |
- Global |
- 124 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
As the global economy mends, the 2021 growth of Home Insulin Delivery (Dosing) Devices will have significant change from previous year. According to our (LP Information) latest study, the global Home Insulin Delivery (Dosing) Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Home Insulin Delivery (Dosing) Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Home Insulin Delivery (Dosing) Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Home Insulin Delivery (Dosing) Devices market, reaching US$ million by the year 2028. As for the Europe Home Insulin Delivery (Dosing) Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Home Insulin Delivery (Dosing) Devices players cover Tandem Diabetes Care, Biocon, Roche Holding AG, and Insulet Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Home Insulin Delivery (Dosing) Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Tandem Diabetes Care
Biocon
Roche Holding AG
Insulet Corporation
B. Braun
BD
Eli Lilly and Company
Novo Nordisk
Sanofi
Wockhardt
Ypsomed Holding
Medtronic
Julphar
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
MannKind
Owen Mumford
SOOIL
Valeritas
West Pharma
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Home Insulin Delivery (Dosing) Devices by Country/Region, 2017, 2022 & 2028
- 2.2 Home Insulin Delivery (Dosing) Devices Segment by Type
- 2.2.1 Insulin Pens
- 2.2.2 Insulin Pumps
- 2.2.3 Insulin Syringes
- 2.2.4 Others
- 2.3 Home Insulin Delivery (Dosing) Devices Sales by Type
- 2.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)
- 2.3.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Type (2017-2022)
- 2.4 Home Insulin Delivery (Dosing) Devices Segment by Application
- 2.4.1 Hospitals Pharmacy
- 2.4.2 Online Pharmacy
- 2.4.3 Retail Pharmacy
- 2.5 Home Insulin Delivery (Dosing) Devices Sales by Application
- 2.5.1 Global Home Insulin Delivery (Dosing) Devices Sale Market Share by Application (2017-2022)
- 2.5.2 Global Home Insulin Delivery (Dosing) Devices Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Application (2017-2022)
3 Global Home Insulin Delivery (Dosing) Devices by Company
- 3.1 Global Home Insulin Delivery (Dosing) Devices Breakdown Data by Company
- 3.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Company (2020-2022)
- 3.1.2 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Company (2020-2022)
- 3.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Company (2020-2022)
- 3.2.1 Global Home Insulin Delivery (Dosing) Devices Revenue by Company (2020-2022)
- 3.2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Company (2020-2022)
- 3.3 Global Home Insulin Delivery (Dosing) Devices Sale Price by Company
- 3.4 Key Manufacturers Home Insulin Delivery (Dosing) Devices Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Home Insulin Delivery (Dosing) Devices Product Location Distribution
- 3.4.2 Players Home Insulin Delivery (Dosing) Devices Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Home Insulin Delivery (Dosing) Devices by Geographic Region
- 4.1 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Geographic Region
- 4.2 World Historic Home Insulin Delivery (Dosing) Devices Market Size by Country/Region (2017-2022)
- 4.2.1 Global Home Insulin Delivery (Dosing) Devices Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue by Country/Region
- 4.3 Americas Home Insulin Delivery (Dosing) Devices Sales Growth
- 4.4 APAC Home Insulin Delivery (Dosing) Devices Sales Growth
- 4.5 Europe Home Insulin Delivery (Dosing) Devices Sales Growth
- 4.6 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales Growth
5 Americas
- 5.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country
- 5.1.1 Americas Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
- 5.1.2 Americas Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
- 5.2 Americas Home Insulin Delivery (Dosing) Devices Sales by Type
- 5.3 Americas Home Insulin Delivery (Dosing) Devices Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region
- 6.1.1 APAC Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022)
- 6.1.2 APAC Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022)
- 6.2 APAC Home Insulin Delivery (Dosing) Devices Sales by Type
- 6.3 APAC Home Insulin Delivery (Dosing) Devices Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Home Insulin Delivery (Dosing) Devices by Country
- 7.1.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
- 7.1.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
- 7.2 Europe Home Insulin Delivery (Dosing) Devices Sales by Type
- 7.3 Europe Home Insulin Delivery (Dosing) Devices Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices by Country
- 8.1.1 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Type
- 8.3 Middle East & Africa Home Insulin Delivery (Dosing) Devices Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Home Insulin Delivery (Dosing) Devices
- 10.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices
- 10.4 Industry Chain Structure of Home Insulin Delivery (Dosing) Devices
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Home Insulin Delivery (Dosing) Devices Distributors
- 11.3 Home Insulin Delivery (Dosing) Devices Customer
12 World Forecast Review for Home Insulin Delivery (Dosing) Devices by Geographic Region
- 12.1 Global Home Insulin Delivery (Dosing) Devices Market Size Forecast by Region
- 12.1.1 Global Home Insulin Delivery (Dosing) Devices Forecast by Region (2023-2028)
- 12.1.2 Global Home Insulin Delivery (Dosing) Devices Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Home Insulin Delivery (Dosing) Devices Forecast by Type
- 12.7 Global Home Insulin Delivery (Dosing) Devices Forecast by Application
13 Key Players Analysis
- 13.1 Tandem Diabetes Care
- 13.1.1 Tandem Diabetes Care Company Information
- 13.1.2 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Offered
- 13.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Tandem Diabetes Care Main Business Overview
- 13.1.5 Tandem Diabetes Care Latest Developments
- 13.2 Biocon
- 13.2.1 Biocon Company Information
- 13.2.2 Biocon Home Insulin Delivery (Dosing) Devices Product Offered
- 13.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Biocon Main Business Overview
- 13.2.5 Biocon Latest Developments
- 13.3 Roche Holding AG
- 13.3.1 Roche Holding AG Company Information
- 13.3.2 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Offered
- 13.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Roche Holding AG Main Business Overview
- 13.3.5 Roche Holding AG Latest Developments
- 13.4 Insulet Corporation
- 13.4.1 Insulet Corporation Company Information
- 13.4.2 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Offered
- 13.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Insulet Corporation Main Business Overview
- 13.4.5 Insulet Corporation Latest Developments
- 13.5 B. Braun
- 13.5.1 B. Braun Company Information
- 13.5.2 B. Braun Home Insulin Delivery (Dosing) Devices Product Offered
- 13.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 B. Braun Main Business Overview
- 13.5.5 B. Braun Latest Developments
- 13.6 BD
- 13.6.1 BD Company Information
- 13.6.2 BD Home Insulin Delivery (Dosing) Devices Product Offered
- 13.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 BD Main Business Overview
- 13.6.5 BD Latest Developments
- 13.7 Eli Lilly and Company
- 13.7.1 Eli Lilly and Company Company Information
- 13.7.2 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Offered
- 13.7.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Eli Lilly and Company Main Business Overview
- 13.7.5 Eli Lilly and Company Latest Developments
- 13.8 Novo Nordisk
- 13.8.1 Novo Nordisk Company Information
- 13.8.2 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Offered
- 13.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 Novo Nordisk Main Business Overview
- 13.8.5 Novo Nordisk Latest Developments
- 13.9 Sanofi
- 13.9.1 Sanofi Company Information
- 13.9.2 Sanofi Home Insulin Delivery (Dosing) Devices Product Offered
- 13.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Sanofi Main Business Overview
- 13.9.5 Sanofi Latest Developments
- 13.10 Wockhardt
- 13.10.1 Wockhardt Company Information
- 13.10.2 Wockhardt Home Insulin Delivery (Dosing) Devices Product Offered
- 13.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Wockhardt Main Business Overview
- 13.10.5 Wockhardt Latest Developments
- 13.11 Ypsomed Holding
- 13.11.1 Ypsomed Holding Company Information
- 13.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Offered
- 13.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 Ypsomed Holding Main Business Overview
- 13.11.5 Ypsomed Holding Latest Developments
- 13.12 Medtronic
- 13.12.1 Medtronic Company Information
- 13.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Product Offered
- 13.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.12.4 Medtronic Main Business Overview
- 13.12.5 Medtronic Latest Developments
- 13.13 Julphar
- 13.13.1 Julphar Company Information
- 13.13.2 Julphar Home Insulin Delivery (Dosing) Devices Product Offered
- 13.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.13.4 Julphar Main Business Overview
- 13.13.5 Julphar Latest Developments
- 13.14 Beta Bionics
- 13.14.1 Beta Bionics Company Information
- 13.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Offered
- 13.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.14.4 Beta Bionics Main Business Overview
- 13.14.5 Beta Bionics Latest Developments
- 13.15 Copernicus
- 13.15.1 Copernicus Company Information
- 13.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Product Offered
- 13.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.15.4 Copernicus Main Business Overview
- 13.15.5 Copernicus Latest Developments
- 13.16 Dance Biopharm
- 13.16.1 Dance Biopharm Company Information
- 13.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Offered
- 13.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.16.4 Dance Biopharm Main Business Overview
- 13.16.5 Dance Biopharm Latest Developments
- 13.17 Debiotech
- 13.17.1 Debiotech Company Information
- 13.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Product Offered
- 13.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.17.4 Debiotech Main Business Overview
- 13.17.5 Debiotech Latest Developments
- 13.18 MannKind
- 13.18.1 MannKind Company Information
- 13.18.2 MannKind Home Insulin Delivery (Dosing) Devices Product Offered
- 13.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.18.4 MannKind Main Business Overview
- 13.18.5 MannKind Latest Developments
- 13.19 Owen Mumford
- 13.19.1 Owen Mumford Company Information
- 13.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Offered
- 13.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.19.4 Owen Mumford Main Business Overview
- 13.19.5 Owen Mumford Latest Developments
- 13.20 SOOIL
- 13.20.1 SOOIL Company Information
- 13.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Product Offered
- 13.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.20.4 SOOIL Main Business Overview
- 13.20.5 SOOIL Latest Developments
- 13.21 Valeritas
- 13.21.1 Valeritas Company Information
- 13.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Product Offered
- 13.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.21.4 Valeritas Main Business Overview
- 13.21.5 Valeritas Latest Developments
- 13.22 West Pharma
- 13.22.1 West Pharma Company Information
- 13.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Product Offered
- 13.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.22.4 West Pharma Main Business Overview
- 13.22.5 West Pharma Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Home Insulin Delivery (Dosing) Devices. Industry analysis & Market Report on Home Insulin Delivery (Dosing) Devices is a syndicated market report, published as Global Home Insulin Delivery (Dosing) Devices Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Home Insulin Delivery (Dosing) Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
